Dungan 2014 — AWARD-6 Dulaglutide vs Liraglutide

The Lancet·October 11, 2014

Kathleen M. Dungan, Frederick D. Wysham, Tina Vilsbøll, Nayyar Iqbal, Paula M. A. Blonde, AWARD-6 Investigators

Summary

AWARD-6 compared once-weekly dulaglutide with once-daily liraglutide and found dulaglutide noninferior for glycemic control in metformin-treated type 2 diabetes.

Study Details

Study Design

Randomized open-label phase 3 non-inferiority trial

Indication

Type 2 diabetes inadequately controlled on metformin

Intervention

Once-weekly dulaglutide vs once-daily liraglutide

Species

Human

Sample Size

599 subjects

Risk of Bias Assessment

Open-label; sponsor-funded